INTI
Inhibitor Therapeutics, Inc.
Key Financials
Revenue
$0
NaN%
Operating Income
$-3426653
↑ 6.3%
Net Income
$-3300337
↑ 1.2%
EPS (Diluted)
$-0.02
0.0%
Total Assets
$2.5M
↓ 55.9%
Total Liabilities
$3.8M
↑ 2.5%
Shareholders' Equity
$-1291912.00
↓ 165.1%
Operating Cash Flow
$-3231370.00
↑ 0.1%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | INTI |
| Company Name | Inhibitor Therapeutics, Inc. |
| CIK | 1042418 |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | (813) 766-2462 |